Develop initial or update safety signal detection and management documents for global developmental and marketed products to support and enhance appropriate signal detection activities and robust safety evaluation Review and/or develop relevant epidemiology sections and/or papers for relevant conferences and/or peer-reviewed journals as assigned Develop or support development of instruments for epidemiological assessment strategies and safety surveillance in coordination with Biostatistics Participate in plan/design, execute or contribute to development of observational studies and interventional studies for assigned global developmental and marketed products Develop epidemiological assessment and safety surveillance plan for assigned projects or studies Review epidemiology data in supporting the development of risk management plan/risk evaluation and mitigation strategies (REMS) and other safety related documents Contribute to the design, implementation, and management of safety studies and clinical trials Search and review epidemiological data and safety literature in supporting development of Ad hoc or regular safety submissions Accountable for epidemiology sections of investigator's brochures, risk management plans, aggregate safety reports (DSUR and PSUR), and responses to health agency's inquiries for global development and post-marketing products Perform safety data evaluation and risk assessment for assigned drug products Provide or contribute to the materials used for Safety meetings including but not limited to the Clinical Safety Team, Data Monitoring Committee, Global Safety Data Monitoring Committee, Data and Safety Monitoring Board (DSMB) Contribute epidemiology input to GST Working Group meetings, Signal Detection meetings and other Global Drug Safety and Evaluation Center (GDSEC) meetings as assigned Performs other departmental duties as assigned Qualifications Education:Graduate degree (PhD, MD, MS, MPH) in a relevant field is required: Doctoral degree with at least 2 years of industry experience, academia, and/or regulatory agency Master's degree with 6+ years of experience in a national/local public health agency, regulatory agency, biopharma, and/or the medical device industry (including at least 1 to 2 years of biopharma or medical device industry experience) Professional Experience:Experience and training in public health, pharmacy, health services research, health outcomes research, epidemiology, biostatistics or other relevant fields Familiarity and experience with the development and implementation of epidemiology research strategies Expertise in Biostatistics, Epidemiology/ secondary database analyses (e.g., claims, national survey data, etc.), Psychometrics Demonstrated experience as a member of a product or project team Experience in scientific writing of peer-reviewed, academic and/or public health literature Familiarity with Drug Development and Phase 1-4 clinical trials Knowledge and Skills:Strong understanding of research methodology and statistics, as well as strong technical writing, and strong ability to critically review published scientific literature Strong verbal and written communication, presentation skills, including experience Critical thinking and problem-solving skills, ability to set priorities and develop strategies/studies to answer complex research questions Experience managing multiple projects, often complex in nature and with both internal and external stakeholders under short timelines Ability to analyze and interpret safety data Good understanding of advanced design and analysis techniques used in the analysis of secondary data (e.g., matching, multivariate regression, meta-analysis, etc.) Ability to conceptualize the presentation of results (e.g., develop layout of tables and figures for inclusion in analysis plans) Working knowledge of 2 or more secondary database types (e.g., claims, surveys, electronic medical records) Working knowledge/ability to use standard statistical packages (i.e. SAS, STATA, etc) Ability to contribute to written processes to ensure consistent and quality deliverables